Heart Rate Variability Assessment in Dialysis Patients by Acupuncture

Sponsor
China Medical University, Taiwan (Other)
Overall Status
Completed
CT.gov ID
NCT04356794
Collaborator
Changhua Christian Hospital (Other)
61
1
2
16.3
3.7

Study Details

Study Description

Brief Summary

Title of the study:Heart Rate Variability Assessment in Dialysis Patients by Acupuncture

Study period: 08/2019 - 07/2021

Institution: the Graduate Institute of Chinese Medical Science, China Medical University/ Changhua Christian Hospital,Taiwan

Aim of the study: To investigate the effect of medical acupuncture in comparison to placebo acupuncture by heart rate variability(HRV)

Design: Prospective randomized trial

Intervention: Experiment group using indwelling fixed needles, N=56 ; Control group using placebo needles, N=56

Outcome measures: International RLS Rating Scale, HRV

Condition or Disease Intervention/Treatment Phase
  • Other: Acupuncture needle with electrical stimulation
  • Other: Sham electroacupuncture
N/A

Detailed Description

RLS occurs in 3-15% of the general population and in 10-30% of patients on maintenance dialysis. End-stage renal disease, a decrease in HRV is typically found, with abnormal HRV being considered an independent risk factor for mortality.While the majority of studies show an initial improvement in symptoms, longer studies and clinical experience show that either treatment efficacy decreases with time, and/or augmentation develops: dopaminergic augmentation has been reported to be the main reason for treatment discontinuation and treatment failure in RLS/WED.

The study randomly assigned to either true acupuncture treatment or placebo/sham acupuncture treatment. Each participant will undergo 8 treatments twice-weekly, for a period of 4 weeks. At the end of the eighth treatment session, each participant will again fill out a IRLSRS questionnaire and HRV test.Then following a 4-week washout period, patients will be crossed over to either placebo/sham or true acupuncture treatment, again 8 twice-weekly treatments, for a period of 4 weeks. At the end of the second treatment regimen all participants will again fill out a IRLSRS questionnaire and HRV test.

Study Design

Study Type:
Interventional
Actual Enrollment :
61 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Heart Rate Variability Assessment in Dialysis Patients by Acupuncture
Actual Study Start Date :
Aug 23, 2019
Actual Primary Completion Date :
Aug 31, 2020
Actual Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Medical electroacupuncture(EA)

EA were treated for 4 weeks, 3 times per week.

Other: Acupuncture needle with electrical stimulation
EA is treated for 4 weeks, 3 times per week.

Sham Comparator: Sham electroacupuncture

Sham acupuncture was performed without stimulation and manipulation to avoid eliciting "De Qi" sensations.It were treated for 4 weeks, 3 times per week.

Other: Sham electroacupuncture
Sham EA is treated for 4 weeks, 3 times per week.

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline International restless legs syndrome rating scale(IRLSRS) at 4 weeks [Baseline, 4 weeks]

    IRLSRS are scored from 4 for the first (top) answer (usually 'very severe') to 0 for the last answer (usually none). All items are scored. The sum of the item scores serves as the scale score.

Secondary Outcome Measures

  1. Change from Baseline HRV(LF,HF, RMSSD, PNN50) at 4 weeks [Baseline, 4 weeks]

    HRV is the measure of the inconsistent gaps between each heartbeat and is used as an index for different aspects of psychology. HRV is an index of the influence of both the parasympathetic nervous system and the sympathetic nervous systems.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Dialysis patients with RLS

  • The symptoms expressed ≧ 3 months and more than twice per week.

  • A score of at least 20 corresponding to severe RLS ( International Restless Legs Syndrome Rating Scale, IRLSRS).Dialysis patients with RLS

Exclusion Criteria:
  • Idiopathic RLS

  • Other movement disorders, various psychiatric and organic disorders, cognitive impairment, or bleeding disorders, on anticoagulant therapy, or cardiac pacemaker.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Changhua Christian Hospital Changhua Taiwan 135

Sponsors and Collaborators

  • China Medical University, Taiwan
  • Changhua Christian Hospital

Investigators

  • Study Director: Lun-Chien Lo, PHD, China Medical University, Taiwan

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Jia-Ming Chen, Principal Investigator, China Medical University, Taiwan
ClinicalTrials.gov Identifier:
NCT04356794
Other Study ID Numbers:
  • Y_105_0300
First Posted:
Apr 22, 2020
Last Update Posted:
Dec 9, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Dec 9, 2021